The Fate of Oral Cavity Verrucous Hyperplasia in a Diagnostic Biopsy: A Conundrum for Subsequent Management

口腔疣状增生在诊断性活检中的预后:后续治疗的难题

阅读:1

Abstract

Oral cavity verrucous growth can be benign, malignant, or have the potential for malignant transformation. The present study aims to explore the hypothesis that all preoperatively diagnosed oral cavity verrucous hyperplasia (OCVH) carry a risk of malignancy in subsequent resection specimens and to re-analyse the risk factors that would indicate malignancy in these patients. This is a retrospective analysis of consecutively diagnosed 30 patients with OCVH on diagnostic biopsy who presented at our institute between February 2018 and January 2021. Among these, patients with malignancy in their final histopathological examination (HPE) were re-analysed for potential clinicopathological risk factors that could anticipate malignancy preoperatively. On subsequent resection, 53.4% (16) of patients had invasive malignancy, 10% (3) of patients had high-grade dysplasia, and 3.3% (1) of patients had mild dysplasia on the final HPE. Thus, only 30% (9) of patients had retained the pre-operative diagnosis of verrucous hyperplasia without dysplasia (3.3% (1) patient was given radical radiotherapy and was excluded from analysis). In addition, age ≥ 50 years (p value = 0.006), repeat biopsies (p value = 0.009), and bone erosion on imaging (p value < 0.001) were clinical-radiological risk factors significantly associated with the risk of malignancy at diagnosis in linear regression analysis. The risk of malignancy can be stratified with proper patient evaluation after a thorough history and clinical-radiological assessment in patients with OCVH on diagnostic biopsy. Thus, these lesions should undergo formal oncologic resection if clinical-radiological suspicion is high, even if preoperative biopsy is negative.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。